Navigation Links
Many breast cancer patients take high doses of antioxidants despite possible consequences
Date:6/7/2009

A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown. Published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that additional research should be undertaken to determine the effects of antioxidant supplementation on the health and survival of breast cancer patients.

Antioxidant supplements include vitamin C, vitamin E, beta-carotene, and selenium. They are found in individual supplements as well as in many multivitamins. Many breast cancer patients believe that antioxidant supplements will protect them from the side effects of breast cancer treatment, help prevent breast cancer recurrence, and improve their overall health. However, the actual effects of taking antioxidants during cancer treatment are poorly understood and the findings to date are mixed. Some physicians believe antioxidants may in fact interfere with radiation and some types of chemotherapy, which often attacks tumor cells by generating reactive oxygen species (ROS), very small molecules that play a role in cell development.

Researchers led by Heather Greenlee, ND, PhD, Assistant Professor of Epidemiology and Medical Oncology (in Medicine) at Columbia University Mailman School of Public Health in New York, investigated the prevalence of antioxidant use in women with breast cancer who participated in the population-based Long Island Breast Cancer Study Project (LIBCSP). LIBCSP, which included more than 1,500 breast cancer patients, began as a federally mandated study that investigated whether breast cancer risk was associated with environmental exposures among women in Nassau and Suffolk counties in New York State. Dr. Greenlee's study is based on the 764 patients who completed a follow-up interview and provided information on antioxidant supplement use.

Among the 764 patients stud
'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... more letters from the North Pole, Textsanta.net l... from Santa , North Pole,...l efficiencies at the North Pole Santa Claus has a...over the globe informed of his Christmas progress ...arch department have identified a large and growin...
(Date:11/26/2009)...search Triangle Dental (RTDental), a leading denta...announced the expansion of its services to include...ug Macmillan. , Durham...d to announce that Dr. Doug Macmillan, an experien...itional advanced training seminar. RTDental&rsquo...
(Date:11/26/2009)...nis & Ennis, P.A. is offering free nationwide ...smin birth control pills who have suffered a Deep ... Heart Attack or other related cardiac issues or h...free at 1-800-856-6405 or go to the firm’s w...n online case evaluation form. , ...
(Date:11/25/2009)...5/PRNewswire/--TheBartleHallConventionCenterwillte...c.9-10,whenKansasCityhoststhelatestinaseriesofmass...liniceventhasthepotentialtobethebiggestoneyet,beca...donweekdaysinsteadofoveraweekend,"SheriWood,execut...dentoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...ftwareandCalgaryScientificInc.,aleadingproviderofs...ionofAegis(TM)Breast4DAdvancedVisualizationsoftwar...o-footprintWebclientbasedmedicalimagingofferingint...owsforzero-footprintaccess-requiringnosoftwaredown...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...army to find clues that may help to build therapie... Dr. Lynn Boyd, an associate professor of biology ...o find out what effect certain enzymes will have, ...y at Redstone Arsenal. While it is not known...
...y may have the potential to reverse impairments in...a first-of-its-kind study published in the Journal... the study was rich in flavanols, naturally-occurr...ucts. These results suggest this flavanol-rich...
...s the breakdown of a brain system that regulates a...a possible target for new drug therapies to help i... of American adults are overweight and around 30 p... The research provides new understanding of ...
... make people even more wary of using agricultural ... a common chemical weed killer could be the hidden...sease, at least those with certain genes that rend...from the University of Alabama,conducted an experi...
...al health conditions are potentially around the co... study. The findings, which were based on anal...d cells, appear online March 6 in the American Jou...t, M.D., Ph.D., professor of psychiatry in the UI ...
...mitted suicide in Assam in the last few months whi.../ as there is virtually no access to treatment. ...le who committed suicide in recent months. The sit...ent of the Assam Network of Positive People (ANPP)...
Other Medicine News:Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 2Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 3Health News:New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function 4Health News:Targeting SOCS-3 can Control Obesity 2Health News:Weed Killer Plays a Pivotal Role in Those With Genetic Vulnerability to Parkinson’ 2Health News:Blood Tests may Be Possible for Mental Health Conditions 2Health News:Assam Reports HIV Suicides, Treatment a Distant Dream 2
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Reg...lopmentofantithromboticaptamerswithactivecontrolag...illbepresentingatthePiperJaffray21stAnnualHealthCa...r.Mazzo,spresentationwillbegivenat1:10pm(EST)onTue...,spipelinewithemphasisontheleaddevelopmentprogram,...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstC...ompanymanufacturingpoint-of-carebloodanalysissyste...fexecutiveofficer,willpresentatthe21stAnnualPiperJ...09at2:00p.m.ET.TheconferencewillbeheldattheNewYork..., Abaxisdevelops,manufacturesandmarketsportableblo...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 1Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 2Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 4Drug May Stem Slide Into Alzheimers for Some 48955 1Drug May Stem Slide Into Alzheimers for Some 48955 2
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
... is variably N-glycosylated. The variation account...tween 43 and 56 kDa. Insulin-like growth factor bi...inity but do not bind insulin. Of the six distinct...t this time, IGFBP-3 has been shown to be the majo...
...00 tests per year through automatic scheduling and...rocessing up to 4 assays on 4 plates simultaneousl... presentation of the results, are controlled by Wi...ube rack) and 256 (POS-ID Linear Rack) samples can...
Immunosimplicity® Is-ENA Screen Test Kit
IMMULITE 2000 IGFBP-3
Medicine Products: